The patient with acute myocardial infarction who does not receive reperfusion treatment

September 2001
Heart;Sep2001, Vol. 86 Issue 3, p243
Academic Journal
The authors reflect on the low number of myocardial infarction patients who receive any reperfusion treatment based on the findings of prospective observational studies. They cite several studies which investigated the effectiveness of thrombolysis and primary angioplasty in acute myocardial infarction. They mention several reasons for the limited use of reperfusion treatment. They also suggest ways to improve reperfusion treatment.


Related Articles

  • Reperfusion Therapy in Acute Myocardial Infarction. Lange, Richard A.; Hillis, L. David // New England Journal of Medicine;3/28/2002, Vol. 346 Issue 13, p954 

    Focuses on the different methods of reperfusion as treatment for patients with acute myocardial infarction. Development of new thrombolytic agents that result in higher rates of early coronary arterial patency and lower rates of bleeding complications; Description of treatment with primary...

  • Use of Reperfusion Therapies in Elderly Patients with Acute Myocardial Infarction. Angeja, B.G.; Gibson, C.M.; Chin, R.; Canto, J.G.; Barron, H.V. // Drugs & Aging;2001, Vol. 18 Issue 8, p587 

    Almost one-third of patients with acute myocardial infarction (AMI) are aged >75 years, and this proportion is expected to increase as the population ages. Mortality and complication rates are particularly high in the elderly, yet reperfusion therapies, including thrombolysis and primary...

  • Association between admission mean platelet volume and ST segment resolution after thrombolytic therapy for acute myocardial infarction. Kırbaş, Özgür; Kurmuş, Özge; Köseoğlu, Cemal; Karaduman, Bilge Duran; Yaşar, Ayşe Saatçi; Alemdar, Recai; Ali, Sina; Bilge, Mehmet // Anatolian Journal of Cardiology / Anadolu Kardiyoloji Dergisi;Dec2014, Vol. 14 Issue 8, p728 

    Objective: Mean platelet volume (MPV), one of the indices of platelet reactivity has been shown to be related to impaired angiographic reperfusion in ST-segment elevation myocardial infarction (STEMI) patients treated with primary angioplasty or thrombolytics. However data regarding MPV and its...

  • Early Reperfusion Assessment and Repeated Thrombolysis in Acute Myocardial Infarction Estimated by Repeated Standard Electrocardiography. Gill, Sabine; Haastrup, Benedikte; Haghfelt, Torben; Dellborg, Mikael; Clemmensen, Peter M. // Cardiology;2000, Vol. 94 Issue 1, p58 

    Thrombolytic therapy with streptokinase (SK) in acute myocardial infarction (AMI) does not result in early reperfusion in approximately 25% of patients. We hypothesized that early repeated thrombolysis with rt-PA in patients with early failed reperfusion would result in myocardial reperfusion....

  • Outcomes of Primary Percutaneous Coronary Intervention at Shahid Gangalal National Heart Centre, Kathmandu, Nepal. Adhikari, Chandra Mani; Bhatta, Yadav Deo; Malla, Rabi; Maskey, Arun; Rajbhandari, Rajib; Regmi, Shyam Raj; Sharma, Ranjit; Kansakar, Subodh; Nepal, Himanshu Prasad; Shrestha, Nagma; Pandey, Rabindra; Prajapati, Dipankar; Raut, Roshan; Dhungana, Murari; Yadav, Dharma Nath; Rauniyar, Binay kumar; Bahadur, K. C. Man // Journal of Advances in Internal Medicine;Jan-Jun2013, Vol. 2 Issue 1, p6 

    Background and Aims- Reperfusion therapy is indicated for patient with acute ST Elevation Myocardial Infarction. Several randomized trials and meta-analyses have shown that Primary Percutaneous Coronary Intervention is better than thrombolysis. Our aim was to determine the outcomes of Primary...

  • Non-invasive treatment of ST elevation myocardial infarction. Jones, J. B.; Docherty, A. // Postgraduate Medical Journal;Dec2007, Vol. 83 Issue 986, p725 

    There is good evidence that timely restoration of coronary blood flow in obstructed infarct related arteries is a significant determinant of both short and long term mortality and morbidity. This is irrespective of whether it is achieved using fibrinolytic therapy or percutaneous coronary...

  • The optimum reperfusion pathway for ST elevation acute myocardial infarction: development of a decision framework. Kendall, J. // Emergency Medicine Journal;Jan2007, Vol. 24 Issue 1, p52 

    This article discusses the use of pharmacological and mechanical reperfusion in the management of acute ST segment elevation acute myocardial infarction (STEMI). An evidence-based report shows that primary precutaneous coronary intervention after STEMI offers short-term mortality, lower...

  • Importance of time to reperfusion in outcome of MI. Dale, David C.; Federman, Daniel D. // Cortlandt Forum;05/25/97, Vol. 10 Issue 5, p22 

    Describes the importance of time to administration of reperfusion therapy as a critical determinant of outcome and one of the determinants of early clinical outcome of myocardial treatment.

  • A randomised dose ranging study of recombinant tissue plasminogen activator in acute myocardial infarction. McNeill, A.J.; Shannon, J.H.; Cunningham, S.R.; Flannery, D.J.; Campbell, N.P.S.; Khan, M.M.; Patterson, G.C.; Webb, S.W.; Adgey, A.A.J. // British Medical Journal (Clinical Research Edition);6/25/1988, Vol. 296 Issue 6639, p1768 

    Evaluates a randomized dose ranging study of recombinant tissue plasminogen activator in acute myocardial infarction in Great Britain. Infusion of tissue plasminogen activator intravenously; Improvement in reperfusion rates regardless of dose; Effectiveness of the recombinant tissue plasminogen...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics